Clinical Trial

A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

Name: A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years — clinical trial record (NCT07413666)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-09.

Trial Details

NCT Number	NCT07413666
Lead Sponsor	Centessa Pharmaceuticals (UK) Limited
Conditions	Healthy Adult Male and Female Volunteers
Enrollment	212 participants
Start Date	2026-02-25
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-25